NCT00580073 2019-12-13
Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinoma of Rectum
University of Wisconsin, Madison
Phase 2 Terminated
Clinical Trials
5 trialsNCT01632306 2019-01-15
A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer
Eli Lilly and Company
Phase 1/2 Terminated
NCT00832299 2018-03-01
Neo-Adjuvant FOLFOX for Rectal Carcinoma
Beth Israel Medical Center
Phase 2 Terminated
NCT01937507 2018-02-07
Hepatic Artery Infusion With FOLFOX in Liver Metastasis From Breast Cancer
Western Regional Medical Center
Phase 2 Terminated
NCT00826800 2015-04-15
Neoadjuvant FOLFOX Plus Bevacizumab Chemotherapy in Patients With Locally Advanced Colon Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Terminated